Company
One
Last checked: Nov 19, 2026Source: SEC EDGAR, openFDA and ClinicalTrials.govMethods & limitations
FDA decisions since 2015
34
510(k), De Novo and PMA
Device trials
0
As lead sponsor, any status
Adverse event reports
60
Received Nov 1, 2025 to Nov 19, 2026
Recall records
28
One per recalled product
This company is not on our public-company list, so only this exact name is matched. Naming a company here is not a recommendation of it or of any security.
Financing
From SEC filings.
We found no SEC financing filings under the name One, so its financing is unknown here. That is common for companies based outside the US, for subsidiaries of larger companies, and for companies funded by founders, grants or customers. A company that changed its name can also be missed.
Not in public filings: valuations, share prices and investors' names. Private databases such as PitchBook and Crunchbase estimate these from press releases and surveys.
Investors
5%+ shareholders from SEC Schedule 13D/13G filings since Dec 1, 2024, and SBIR/STTR grants (NIH through Nov 10, 2026, other agencies through 2023). Venture investors in private rounds are not in public filings.
No 5%+ shareholder filings or SBIR grants found under the name One.
Latest FDA decisions
The 8 newest of 34 since 2015.
- Sapphire Cooling IPL Hair Removal Device (Ice 2.0, Ice 2.1, Ice 2.2, Ice 2.0B, Ice 2.1B, Ice 2.2B)510(k)
K262524 · Decided Sep 18, 2026 · 58 days after receipt
Device type: Light Based Over-The-Counter Hair Removal (OHT) · General & Plastic Surgery
K262341 · Decided Sep 8, 2026 · 60 days after receipt
Device type: Prosthesis, Knee, Patellofemorotibial, Semi-Constrained, Cemented, Polymer/Metal/Polymer (JWH) · Orthopedic Surgery
- 2D Hip Planning Software510(k)
K261352 · Decided Jun 8, 2026 · 45 days after receipt
Device type: System, Image Processing, Radiological (LLZ) · Radiology & Imaging
31 more FDA decisions with a free account
Device trials
Trials on ClinicalTrials.gov that list this company as lead sponsor, most recently updated first.
No device trials list this company as lead sponsor.
Reports received
60
Received Nov 1, 2025 to Nov 19, 2026. Includes 1 of another or unstated type.
Malfunction reports
59
98% of reports
Injury reports
0
0.0% of reports
Death reports
0
0.0% of reports
Adverse event reports received per month
Reports that name this company as manufacturer, by the date FDA received them. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 11 | 0 | 0 | 0 |
| Jan 24 | 14 | 0 | 0 | 0 |
| Feb 24 | 10 | 0 | 0 | 0 |
| Mar 24 | 24 | 0 | 0 | 0 |
| Apr 24 | 2 | 0 | 0 | 0 |
| May 24 | 55 | 1 | 0 | 0 |
| Jun 24 | 6 | 0 | 0 | 0 |
| Jul 24 | 11 | 0 | 0 | 0 |
| Aug 24 | 4 | 0 | 0 | 0 |
| Sep 24 | 12 | 0 | 0 | 0 |
| Oct 24 | 9 | 1 | 0 | 0 |
| Nov 24 | 16 | 0 | 0 | 0 |
| Dec 24 | 7 | 0 | 0 | 0 |
| Jan 25 | 1 | 0 | 0 | 0 |
| Feb 25 | 6 | 0 | 0 | 0 |
| Mar 25 | 10 | 1 | 0 | 0 |
| Apr 25 | 3 | 0 | 0 | 0 |
| May 25 | 11 | 1 | 0 | 0 |
| Jun 25 | 9 | 0 | 0 | 0 |
| Jul 25 | 10 | 0 | 0 | 0 |
| Aug 25 | 5 | 0 | 0 | 0 |
| Sep 25 | 7 | 0 | 0 | 0 |
| Oct 25 | 7 | 0 | 0 | 0 |
| Nov 25 | 4 | 0 | 0 | 0 |
| Dec 25 | 9 | 0 | 0 | 0 |
| Jan 26 | 4 | 0 | 0 | 0 |
| Feb 26 | 4 | 0 | 0 | 0 |
| Mar 26 | 3 | 0 | 0 | 0 |
| Apr 26 | 2 | 0 | 0 | 0 |
| May 26 | 2 | 0 | 0 | 0 |
| Jun 26 | 1 | 0 | 0 | 0 |
| Jul 26 | 11 | 0 | 0 | 0 |
| Aug 26 | 10 | 0 | 0 | 1 |
| Sep 26 | 6 | 0 | 0 | 0 |
| Oct 26 | 3 | 0 | 0 | 0 |
| Nov 26 | 0 | 0 | 0 | 0 |
Device types named most often
Last 12 months, by FDA product code. A company that sells more gets more reports.
1 more in this ranking with a free account
Brand names named most often
Last 12 months, as written on the reports. One product can appear under several spellings.
7 more in this ranking with a free account
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-0200-2027 · Started Jul 29, 2026 · Posted by FDA Oct 21, 2026
Reason given: Lot B26043FM may include EDTA contamination which introduces potassium while chelating calcium in patient samples, leading to falsely elevated potassium (K+) and falsely decreased calcium (Ca++) results which have the potential to cause hyperkalemia.
Cause as FDA categorized it: Nonconforming Material/Component · Device type: Tubes, Vials, Systems, Serum Separators, Blood Collection (JKA)
Z-0571-2026 · Started Aug 19, 2025 · Posted by FDA Nov 19, 2025
Reason given: Some of the Vacuette CAT Serum Separator Clot Activator tubes were manufactured without gel separator, which could yield erroneous assay results and require the patient to return to the lab for recollection or repeat testing. This may result in delayed diagnosis, cause a delay in clinical decision-making or treatment...
Cause as FDA categorized it: Labeling Change Control · Device type: Tubes, Vials, Systems, Serum Separators, Blood Collection (JKA)
Z-0408-2026 · Started Aug 8, 2025 · Posted by FDA Oct 28, 2025
Reason given: Blood collection tubes were manufactured with the label applied too high on the tube, which shifted the printed fill level mark upward, which could result in unnecessary sample rejection and repeat collections.
Cause as FDA categorized it: Under Investigation by firm · Device type: Tubes, Vacuum Sample, With Anticoagulant (GIM)
25 more recall records with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.